Abstract
Kernicterus, thought to be due to severe hyperbilirubinemia, is an uncommon disorder with tragic consequences, especially when it affects healthy term and near-term infants. Early identification, prevention and treatment of severe hyperbilirubinemia should make kernicterus a preventable disease. However, national epidemiologic data are needed to monitor any preventive strategies. Recommendations are provided to obtain prospective data on the prevalence and incidence of severe hyperbilirubinemia and associate mortality and neurologic injury using standardized definitions, explore the clinical characteristics and root causes of kernicterus in children identified in the Kernicterus Pilot Registry, identify and test an indicator for population surveillance, validating systems-based approaches to the management of newborn jaundice, and explore the feasibility of using biologic or genetic markers to identify infants at risk for hyperbilirubinemia. Increased knowledge about the incidence and consequences of severe hyperbilirubinemia is essential to the planning, implementation and assessment of interventions to ensure that infants discharged as healthy from their birth hospitals have a safer transition to home, avoiding morbidity due to hyperbilirubinemia and other disorders.
At a recent NIHCD-sponsored conference, key questions were raised about kernicterus and the need for additional strategies for its prevention. These questions and an approach to their answers form the basis of this report.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Case study on the use of intensive pediatric neurorehabilitation in the treatment of kernicterus
Journal of Clinical Movement Disorders Open Access 03 February 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Johnson L . Hyperbilirubinemia in the term infant: when to worry, when to treat. NY State J Med 1991;91:483–489.
Brown AK, Johnson L . Loss of concern about jaundice and the reemergence of kernicterus in full-term infants in the era of managed care. In: Fanaroff AA, Klaus MH editors. The Year Book of Neonatal and Perinatal Medicine. Philadelphia: Mosby Yearbook; 1996, p. xvii–viii.
Johnson L, Brown AK . A pilot registry for acute and chronic kernicterus in term and near-term infants. Pediatrics Suppl 1999;104:736.
Johnson LH, Bhutani VK, Brown AK . System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr 2002;140:396–403.
AAP Subcommittee on Neonatal Hyperbilirubinemia Neonatal jaundice and kernicterus Pediatrics 2001;108:763–765.
American Academy of Pediatrics Practice Parameter: Management of hyperbilirubinemia in the healthy term newborns. Pediatrics 1994;94:558–565.
From the Centers for Disease Control and Prevention. Kernicterus in full-term infants—United States, 1994–1998. JAMA 2001;286(18):299–300.
Sentinel Event Alert: KI Threatens Healthy Babies. www.JACHO.org.Issue 18, April, 9-11-2000.
Sheridan SE . Testimony at the First National Summit on Medical Errors and Patient Safety Research on 9-11-2000. AHRQ.gov. http://ahrq.gov//news/press/pr2000/summitpr.htm.
Newman TB, Liljestrand P, Escobar GJ . Infants with bilirubin levels of 30 mg/dL or more in a large managed care organization. Pediatrics 2003;111:1303–1311.
Newman TB, Klebanoff MA . Neonatal hyperbilirubinemia and long-term outcome: another look at the Collaborative Perinatal Project. Pediatrics 1993;92:651–657.
Newman TB, Xiong B, Gonzales VM, Escobar GJ . Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization Arch Pediatr Adolesc Med. 2000;154:1140–1147.
Bhutani VK, Johnson LH, Sivieri EM . Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 1999;103:6–14.
Stevenson DK, Fanaroff AA, Maisels MJ, et al. Prediction of hyperbilirubinemia in near-term and term infants Pediatrics. 2001;108:31–39.
Martinez JC, Garcia HO, Otheguy LE, Drummond GS, Kappas A . Control of severe hyperbilirubinemia in full term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin. Pediatrics 1999;103:1–5.
Khurana E, Bhutani VK, Dworanczyk R, Mancini T, Johnson LH . Readmission rates of healthy newborns for severe hyperbilirubinemia and intensive phototherapy in USA. Abstract. Pediatr Res 2003;54:1756A.
Volpe JJ . Bilirubin and brain injury. In: Neurology of the Newborn. 1st ed, 1981; 2nd ed 1987; 3rd ed 1995; 4th ed 2001.
Poland RL . Preventing kernicterus: almost there. J Pediatr 2002;140(4):385–386.
Ip S, Glicken S, Kulig J, O'Brien R, Sege R . Management of Neonatal Hyperbilirubinemia. Summary, Evidence Report/Technology Assessment. Number 65. AHRQ Publication No. 03 E005, March 2002. Agency for Healthcare Research and Quality, Rockville, MD.
Vreman HJ, Verter J, Stevenson DK . Interlaboratory variability of bilirubin measurements. Clin Chem. 1996;42:869–873.
Sheridan SE . Kernicterus parents' group. J Pediatr 2002;141:597.
Bhutani VK, Johnson LH . Newborn jaundice and kernicterus – health and societal perspectives. Indian J Pediatr 2003;70:407–416.
Bhutani VK, Johnson LH, Keren R . Diagnosis and management of hyperbilirubinemia in the term neonate: for a safer first week. Pediatr Clin North Am. (in press).
Watchko JF, Daood MJ, Biniwale M . Understanding neonatal hyperbilirubinemia in the era of genomics. Semin Neonatol 2002;7:143–152.
Dennery PA, Seidman DS, Stevenson DK . Neonatal hyperbilirubinemia. N Engl J Med 2001;344:581–590.
Bancroft JD, Kreamer B, Gourley GR . Gilbert syndrome accelerates development of neonatal jaundice. J Pediatr 1998;132:656–660.
Beutler E, Gelbart T, Demina A . Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci USA 1998;95:8170–8174.
Bosma PJ, Chowdhury JR, Bakker C, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 1995;333:1171–1175.
Kaplan M, Renbaum P, Levy-Lahad E, Hammerman C, Lahad A, Beutler E . Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci USA 1997;94:12128–12132.
Author information
Authors and Affiliations
Additional information
Presented in part at the NICHD Conference, Research on Prevention of Bilirubin-Induced Brain Injury and Kernicterus-From Bench to Bedside, at Bethesda, Md, USA, June 2003.
APPENDIX A
APPENDIX A
Table A1 summarizes the data from Pilot Kernicterus Registry.
Rights and permissions
About this article
Cite this article
Bhutani, V., Johnson, L., Jeffrey Maisels, M. et al. Kernicterus: Epidemiological Strategies for Its Prevention through Systems-Based Approaches. J Perinatol 24, 650–662 (2004). https://doi.org/10.1038/sj.jp.7211152
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7211152
This article is cited by
-
ABO hemolytic disease of the newborn: a need for clarity and consistency in diagnosis
Journal of Perinatology (2023)
-
Management of severe hyperbilirubinemia in the cholestatic neonate: a review and an approach
Journal of Perinatology (2022)
-
Predicting NICU admissions in near-term and term infants with low illness acuity
Journal of Perinatology (2021)
-
Case study on the use of intensive pediatric neurorehabilitation in the treatment of kernicterus
Journal of Clinical Movement Disorders (2020)
-
Extreme neonatal hyperbilirubinemia and kernicterus spectrum disorder in Denmark during the years 2000–2015
Journal of Perinatology (2020)